Mosaic Co (NYSE:MOS) announced its earnings results on Tuesday. The company reported $0.54 earnings per share (EPS) for the quarter, AnalystRatings.Net reports. The company had revenue of $2.00 billion for the quarter, compared to the consensus estimate of $2.30 billion. Mosaic Co (NYSE:MOS) shares after opening at $49.84 moved to $49.88 on last trade day and at the end of the day closed at $49.71. Company price to sales ratio in past twelve months was calculated as 2.00 and price to cash ratio as 3.59. Mosaic Co (NYSE:MOS) showed a negative weekly performance of -0.06%.
Potash Corporation of Saskatchewan Inc. (USA) (NYSE:POT) reported earnings of $0.40 per share ($340 million) for the first quarter of 2014, a total that included a $69 million ($0.06 per share) special dividend from our investment in Israel Chemicals Ltd. (ICL) as well as a $38 million ($0.04 per share) non-cash impairment charge related to our investment in Sinofert Holdings Limited (Sinofert). Potash Corp./Saskatchewan (USA) (NYSE:POT) shares fell -0.90% in last trading session and ended the day on $36.24. POT return on equity ratio is recorded as 16.00% and its return on assets is 8.70%. Potash Corp./Saskatchewan (USA) (NYSE:POT) yearly performance is -10.61%.
RetailMeNot, Inc. (NASDAQ:SALE) which operates the world’s largest marketplace for digital offers, reported its financial results for the first quarter ended March 31, 2014 RetailMeNot Inc (NASDAQ:SALE) shares moved up 3.94% in last trading session and was closed at $32.71 while trading in range of $30.01- $33.68 – RetailMeNot Inc (NASDAQ:SALE) year to date (YTD) performance is 13.62%.
CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc. (NASDAQ:MGNX) a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, have entered into an agreement to further develop the production process for transfer and clinical manufacturing of one of MacroGenics’ product candidates. MacroGenics Inc (NASDAQ:MGNX) weekly performance is -3.40%. On last trading day company shares ended up $20.16. MacroGenics Inc (NASDAQ:MGNX) distance from 50-day simple moving average (SMA50) is -29.76%. Analysts mean target price for the company is $56.25.